Mannitol For Cerebral Oedema After Intracerebral Haemorrhage (Mace-Ich): A Feasibility Trial

被引：0
|
作者：
Krishnan, K. [1 ]
Craig, J. [2 ]
Dawson, J. [3 ]
Dineen, R. [4 ]
England, T. [5 ]
Havard, D. [2 ]
Hewson, D. [6 ]
Macleod, M. [7 ]
Roffe, C. [8 ]
Sprigg, N. [2 ]
Woodhouse, L. [2 ]
Bath, P. [2 ]
机构：
[1] Nottingham Univ Hosp NHS Trust, Stroke, Nottingham, England
[2] Univ Nottingham, Sch Med, Stroke Trials Unit, Mental Hlth & Clin Neurosci, Nottingham, England
[3] Univ Glasgow, Sch Cardiovasc & Metab Hlth, Glasgow, Scotland
[4] Univ Nottingham, Sch Med, Mental Hlth & Clin Neurosci, Radiol Sci, Nottingham, England
[5] Univ Hosp Derby & Burton NHS Fdn Trust, Derby Stroke Ctr, Derby, England
[6] Nottingham Univ Hosp NHS Trust, Dept Anaesthesia & Crit Care, Nottingham, England
[7] Univ Aberdeen, Inst Med Sci, Dept Med & Therapeut, Aberdeen, Scotland
[8] Keele Univ, Sch Med, Keele, England
来源：
INTERNATIONAL JOURNAL OF STROKE | 2024年 / 19卷 / 3_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：69 / 69
页数：1
相关论文
共 50 条
  • [41] The feasibility of dual-energy CT to predict the probability of symptomatic intracerebral haemorrhage after successful mechanical thrombectomy
    Ma, C.
    Hui, Q.
    Gao, X.
    Xu, D.
    Tang, B.
    Pen, M.
    Lui, S.
    Chen, X.
    CLINICAL RADIOLOGY, 2021, 76 (04) : 316.e9 - 316.e18
  • [42] Phase II randomised, placebo-controlled, clinical trial of interleukin-1 receptor antagonist in intracerebral haemorrhage: BLOcking the Cytokine IL-1 in ICH (BLOC-ICH)
    Parry-Jones, Adrian R.
    Stocking, Katie
    MacLeod, Mary Joan
    Clarke, Brian
    Werring, David J.
    Muir, Keith W.
    Vail, Andy
    EUROPEAN STROKE JOURNAL, 2023, 8 (03) : 819 - 827
  • [43] Targeted temperature management after intracerebral hemorrhage (TTM-ICH): methodology of a prospective randomized clinical trial
    Rincon, Fred
    Friedman, David P.
    Bell, Rodney
    Mayer, Stephan A.
    Bray, Paul F.
    INTERNATIONAL JOURNAL OF STROKE, 2014, 9 (05) : 646 - 651
  • [44] Association of Serum GFAP With Hematoma Expansion and Poor Outcome After Intracerebral Hemorrhage: The Factor VII for ICH Trial
    Leasure, Audrey C.
    Vanent, Kevin N.
    Bevers, Matthew
    Kimberly, William T.
    Mayer, Stephan A.
    Steiner, Thorsten
    Matouk, Charles
    Sansing, Lauren H.
    Falcone, Guido J.
    Sheth, Kevin N.
    STROKE, 2021, 52
  • [45] Clinical and radiological predictors of cognitive impairment after intracerebral haemorrhage at day 365: data from the Tranexamic acid for hyperacute primary IntraCerebral Haemorrhage (TICH-2) trial
    Belcher, A.
    Woodhouse, L.
    Bath, P. M.
    Sprigg, N.
    INTERNATIONAL JOURNAL OF STROKE, 2019, 14 (4_SUPPL) : 15 - 15
  • [46] ASPIRING to determine effectiveness of antiplatelet therapy after intracerebral haemorrhage: Rationale for a new international clinical trial
    Hankey, G. J.
    Anderson, C. S.
    Salman, Al-Shahi R.
    INTERNATIONAL JOURNAL OF STROKE, 2021, 16 (1_SUPPL) : 12 - 12
  • [47] PREVENTION OF HYPERTENSIVE INJURY TO THE BRAIN BY INTENSIVE TREATMENT IN INTRACEREBRAL HAEMORRHAGE (PROHIBIT-ICH): PROTOCOL FOR A RANDOMISED CONTROLLED TRIAL OF TELEMETRIC HOME BP MONITORING
    McGurgan, Iain
    Butt, Shahena
    Silver, Louise
    Werring, David
    Rothwell, Peter
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2019, 90 (12): : E72 - E73
  • [48] Clevidipine rapidly and safely reduces blood pressure in acute intracerebral haemorrhage; The ACCELERATE trial cover title: clevidipine rapidly and safely reduces BP in ICH
    Bergese, S. D.
    Graffagnino, C.
    Love, J.
    Schneider, D.
    LaPointe, M.
    Lazaridis, C.
    Lee, K.
    Lynch, G.
    EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 : 50 - 50
  • [49] Implementing a Goal-Directed Care Bundle after Acute Intracerebral Haemorrhage: Process Evaluation for the Third INTEnsive Care Bundle with Blood Pressure Reduction in Acute Cerebral Haemorrhage Trial Study in China
    Ouyang, Menglu
    Anderson, Craig S.
    Song, Lili
    Jan, Stephen
    Sun, Lingli
    Cheng, Guojuan
    Chu, Honglin
    Hu, Xin
    Ma, Lu
    Chen, Xiaoying
    You, Chao
    Liu, Hueiming
    CEREBROVASCULAR DISEASES, 2022, 51 (03) : 373 - 383
  • [50] Efficacy and safety of glibenclamide therapy after intracerebral haemorrhage (GATE-ICH): A multicentre, prospective, randomised, controlled, open-label, blinded-endpoint, phase 2 clinical trial
    Zhao, Jingjing
    Song, Changgeng
    Li, Deshuai
    Yang, Xiai
    Yu, Liping
    Wang, Kangjun
    Wu, Jun
    Wang, Xiaofeng
    Li, Dongsong
    Zhang, Bo
    Li, Binyong
    Guo, Jun
    Feng, Weikui
    Fu, Feng
    Gu, Xinrong
    Qian, Jian
    Li, Jialong
    Yuan, Xiangjun
    Liu, Qiuwu
    Chen, Jiang
    Wang, Xiaocheng
    Liu, Yi
    Wei, Dong
    Wang, Ling
    Shang, Lei
    Yang, Fang
    Jiang, Wen
    ECLINICALMEDICINE, 2022, 53
12345